High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer – a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA)

Author： Haugnes Hege S.   Laurell Anna   Stierner Ulrika   Bremnes Roy M.   Dahl Olav   Cavallin-Ståhl Eva   Cohn-Cedermark Gabriella  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.51, Iss.2, 2012-02, pp. : 168-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support

By Kollmannsberger C.   Schleucher N.   Rick O.   Metzner B.   Hartmann J.T.   Schoffski P.   Beyer J.   Casper J.   Sosada M.   Schmoll H.-J.   Bohlke I.   Meisner C.   Kanz L.   Bokemeyer C.  

European Journal of Cancer, Vol. 39, Iss. 6, 2003-04 ,pp. : 775-782

Elsevier

Access to resources Recommend Favorite

Very High-dose Chemotherapy with Autologous Peripheral Stem Cell Support in Advanced Ovarian Cancer

By Benedetti-Panici P.   Greggi S.   Scambia G.   Salerno M.G.   Baiocchi G.   Laurelli G.   Menichella G.   Pierelli L.   Foddai M.L.   Serafini R.   Bizzi B.   Mancuso S.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 1987-1992

Elsevier

Access to resources Recommend Favorite

Changes in the Incidence and Mortality of Testicular Cancer in Scotland with Particular Reference to the Outcome of Older Patients Treated for Non-seminomatous Germ Cell Tumours

By Hatton M.Q.F.   Paul J.   Harding M.   MacFarlane G.   Robertson A.G.   Kaye S.B.  

European Journal of Cancer, Vol. 31, Iss. 9, 1995-09 ,pp. : 1487-1491

Elsevier

Access to resources Recommend Favorite

High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: First results of a randomized trial

By Verrill Mark  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 41-43

Informa Healthcare

Access to resources Recommend Favorite

Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT)

By Donohue J.P.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 2, 2003-03 ,pp. : 129-132

Elsevier

Access to resources Recommend Favorite